Table 1 Summary of the impact of combination therapy, MFT and sequential application on useful therapeutic life and the spread of multi-resistant genotypes assuming drug usage typical in control scenarios

From: Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach